SHREE GANESH REMEDIES
Quarterly Results Analysis [Dec2024]
SHREE GANESH REMEDIES Quarterly Results
Consolidated | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2021 UnAudited |
Sep2021 UnAudited |
Dec2020 UnAudited |
Sep2020 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹27 Cr | ₹32 Cr | ₹25 Cr | ₹37 Cr | ₹21 Cr | ₹17 Cr | ₹13 Cr | ₹12 Cr |
Expenses | ₹17 Cr | ₹21 Cr | ₹17 Cr | ₹20 Cr | ₹15 Cr | ₹13 Cr | ₹10 Cr | ₹7 Cr |
Operating Income | ₹10 Cr | ₹11 Cr | ₹8 Cr | ₹17 Cr | ₹6 Cr | ₹4 Cr | ₹3 Cr | ₹4 Cr |
Other Income | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr |
Profit Before Tax | ₹8 Cr | ₹9 Cr | ₹6 Cr | ₹16 Cr | ₹6 Cr | ₹4 Cr | ₹3 Cr | ₹4 Cr |
Profit After Tax | ₹5 Cr | ₹6 Cr | ₹5 Cr | ₹13 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
EPS | ₹4.22 | ₹4.99 | ₹3.62 | ₹10.00 | ₹3.47 | ₹2.50 | ₹2.29 | ₹2.29 |
Industry Peers & Returns | 1W | 1M | 1Y |
SHREE GANESH REMEDIES | -0.2% | 6.8% | 9.6% |
SUN PHARMACEUTICAL INDUSTRIES | -1.5% | 9.1% | 9.1% |
DIVIS LABORATORIES | -4.9% | -0.6% | 59.1% |
CIPLA | -1.8% | 1% | 0.5% |
TORRENT PHARMACEUTICALS | 1.6% | 12.1% | 21.8% |
DR REDDYS LABORATORIES | -3% | -0.9% | -7.7% |
MANKIND PHARMA | 1.1% | 7.6% | 1.3% |
ZYDUS LIFESCIENCES | -2.2% | -0.6% | -9.3% |
LUPIN | -2.7% | 1% | 30.1% |
SHREE GANESH REMEDIES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -16.33 % |
Y-o-Y | 28.04 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹27 Cr | -16.33 | |
Sep2024 | ₹32 Cr | 30.48 | |
Jun2024 | ₹25 Cr | -33.62 | |
Mar2024 | ₹37 Cr | 76.69 | |
Dec2021 | ₹21 Cr | 24.51 | |
Sep2021 | ₹17 Cr | 27.93 | |
Dec2020 | ₹13 Cr | 15.11 | |
Sep2020 | ₹12 Cr | - |
SHREE GANESH REMEDIES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -12.47 % |
Y-o-Y | 71.37 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹10 Cr | -12.47 | |
Sep2024 | ₹11 Cr | 39.22 | |
Jun2024 | ₹8 Cr | -52.02 | |
Mar2024 | ₹17 Cr | 193.09 | |
Dec2021 | ₹6 Cr | 30.00 | |
Sep2021 | ₹4 Cr | 40.19 | |
Dec2020 | ₹3 Cr | -24.65 | |
Sep2020 | ₹4 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 4.60 % |
Y-o-Y | 33.83 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 36.59% | 4.60 | |
Sep2024 | 34.98% | 6.71 | |
Jun2024 | 32.78% | -27.73 | |
Mar2024 | 45.36% | 65.91 | |
Dec2021 | 27.34% | 4.39 | |
Sep2021 | 26.19% | 9.58 | |
Dec2020 | 23.9% | -34.54 | |
Sep2020 | 36.51% | - |
SHREE GANESH REMEDIES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -15.34 % |
Y-o-Y | 29.06 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹5 Cr | -15.34 | |
Sep2024 | ₹6 Cr | 37.79 | |
Jun2024 | ₹5 Cr | -63.05 | |
Mar2024 | ₹13 Cr | 199.45 | |
Dec2021 | ₹4 Cr | 39.23 | |
Sep2021 | ₹3 Cr | 8.91 | |
Dec2020 | ₹3 Cr | -10.44 | |
Sep2020 | ₹3 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 1.21 % |
Y-o-Y | 0.80 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 20.05 % | 1.21 | |
Sep2024 | 19.81 % | 5.60 | |
Jun2024 | 18.76 % | -44.35 | |
Mar2024 | 33.71 % | 69.48 | |
Dec2021 | 19.89 % | 11.80 | |
Sep2021 | 17.79 % | -14.84 | |
Dec2020 | 20.89 % | -22.20 | |
Sep2020 | 26.85 % | - |
SHREE GANESH REMEDIES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -15.43 % |
Y-o-Y | 21.61 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹4.22 | -15.43 | |
Sep2024 | ₹4.99 | 37.85 | |
Jun2024 | ₹3.62 | -63.80 | |
Mar2024 | ₹10 | 188.18 | |
Dec2021 | ₹3.47 | 38.80 | |
Sep2021 | ₹2.5 | 9.17 | |
Dec2020 | ₹2.29 | 0.00 | |
Sep2020 | ₹2.29 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD